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Abstract: The senna leaf contains a powerful natural laxative called anthraquinone. 
Despite this indication, the quality control of this raw material is not strict, compared to 
other substances with pharmacological properties, which is unacceptable. Therefore, the 
present investigation sought to evaluate physicochemical and microbiological quality 
aspects of the senna leaf tisanes from two brands commercialized in Costa Rica, through 
various assays established in the current Central American Technical Regulation (RTCA) 
11.03.56.09. The aforementioned was made in order to identify and compare whether 
these aspects are constant or not for the different batches of the same product for each of 
the brands. For that reason, the following assays were done for three batches of two 
different brands: Labeling, minimum fill, organoleptic, foreign organic matter, 
identification, loss on drying, total ash, acid-insoluble ash, microbial enumerations and 
determination of specific microorganisms. The results show that the batches of both 
brands are in compliance for all the assays, except for the labeling assay (six of the 23 
items required for primary and secondary packaging labeling were not found). For all of 
the above, the raw material commercialized in Costa Rica meet the quality standards 
according with the requirements of the RTCA. Also, there is reproducibility for the 
characteristics of the senna leaf between the different batches in each one of the two 
commercialized brands. This is an indication that the raw material used maintains the 
quality characteristics required to favor its efficiency and safety. 
Keywords: senna leaf, tisane, Costa Rica, quality control, Central American Technical 
Regulation. 
 
INTRODUCTION 
A medicinal plant is defined as one in which 
one or more of its organs contain substances that can be 
used for therapeutic purposes or that are precursors for 
the synthesis of useful drugs [1]. One of the 
administration forms in which these natural compounds 
have been used for the prevention and treatment of 
diseases is the tisane [2]. It is obtained by using water 
as a vehicle through which the active principles of the 
vegetal material used pass [3]. 
 
A plant of interest used in tisanes is the senna 
leaf. Its scientific name is Cassia angustifolia Vahl. It 
belongs to the Caesalpinaceae family, Fabaceae 
subfamily. It is native from Saudi Arabia, grows in arid 
areas of Sudan and Egypt, and is grown commercially 
in India [4]. The tree is a small shrub type, with 
irregular and scattered, sparse, extended glass, with thin 
branches in the shape of an umbrella. Its flowers are 
very showy, they appear in terminal inflorescences, of 
great color varying from yellow to red, even with mixed 
tones [5]. In addition, it is one of the crops in the world 
presented in different official pharmaceutical books 
(pharmacopoeias) for its therapeutic properties [5]. Its 
uses include blood purifier, laxative to relieve 
constipation and treatment for skin diseases. It contains 
a powerful natural laxative called anthraquinone and is 
approved by the World Health Organization (WHO) 
[6]. 
 
The plant´s biological activity is attributed to 
anthraquinones called sennosides A and B, specifically 
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to its aglycone portion. The breakdown of 
anthraquinones can occur in two ways. The flora of the 
intestine can hydrolyze them in a similar way to free 
active aglycone. Alternatively, in the presence of bile 
and sugar, the free aglycone can be absorbed into the 
bloodstream and subsequently, secreted into the colon. 
The final result is the stimulation of the Auerbach 
plexus, which results in an increase of the intestinal 
muscle contraction. Additionally, its mucilage content 
decreases the absorption of the organism fluids, causing 
the final laxative action [7]. 
 
Despite these indications, the quality control of 
these products is not strict compared to other substances 
with pharmacological properties, which is unacceptable. 
Little is known about the effects of these extracts on the 
people health [8]. Therefore, they must be examined to 
assess their quality, medicinal efficacy and safety [9]. 
Likewise, the quality of the raw material is dependent 
on the environmental conditions, since it can be 
affected by temperature or certain biotic factors 
changes, as well as the harvesting season or the age of 
the plant, which can give qualitative and quantitative 
variations in the different manufactured batches [10]. 
 
Therefore, the present investigation sought to 
evaluate physicochemical and microbiological quality 
aspects of the senna leaf tisanes of two brands 
commercialized in Costa Rica, through various assays 
established in the current Central American Technical 
Regulation (RTCA) 11.03.56.09 [11]. The 
aforementioned was made in order to identify and 
compare whether these aspects are constant or not for 
the different batches of the same product for each of the 
brands. 
 
MATERIALS AND METHODS 
Senna leaf product sampling 
Three batches of brand 1 (1, 2 and 3) and three 
other batches of brand 2 (4, 5 and 6) of senna leaf 
tisanes were purchased in different supermarkets and 
establishments located in the Greater Metropolitan Area 
of Costa Rica (5 boxes per batch). 
 
Selection of procedures for the physicochemical and 
microbiological assays carried out 
Different assays established in the RTCA 
11.03.56.09 were carried out [11]. The requirement 
indicated in this document for the choice of each one is 
its presence in an official Costa Rican book for quality 
control of natural products, such as different countries 
and organizations pharmacopoeias. 
 
Labeling assay 
The labeling assay was carried out following 
the procedure established by the RTCA 11.04.41:06 
[12]. It indicates different items to be reviewed in both 
primary and secondary packaging. They are presented 
in Table 1. 
 
Minimum fill assay 
Following the procedure of general chapter 
<755> of the United States Pharmacopeia (USP) 40 
[13], a sample of 10 sealed bags of each batch of the 
selected brand were taken, were cut to open and extract 
quantitatively the content in a way that there was no 
loss in the process. Then, the contents of each bag were 
individually weighed on an ADAM® PW254 analytical 
balance. The percentage of labeling was determined by 
dividing the weight of the tisane content by the weight 
indicated on the secondary packaging of each of the 
batches and the result was multiplied by 100. The 
average content of the 10 tisanes should not be less than 
that declared on the labeling, and the weight of each 
tisane should not be less than 90 % of what was stated 
for the product to be in compliance. 
 
Organoleptic assays 
Ten tisanes were used to establish the 
organoleptic characteristics (smell, color, texture) as 
indicated in the British Pharmacopoeia (BP) for the 
senna leaf [14]. The inspection was done directly using 
a lamp for proper lighting. The product was in 
compliance if it had a slight characteristic odor, a 
greenish-grayish or greenish-brown color and a smooth 
texture. 
 
Determination of foreign organic matter 
Ten tisanes were taken and their content was 
spread on a white surface, forming a thin layer and 
carefully observed with the help of a Konus® loupe and 
tweezers. Then, the foreign organic matter was 
organized in foreign organs and foreign elements as 
stipulated in the British Pharmacopoeia [14]. Each 
material was weighed separately on an Adam® PW254 
analytical balance and the percentage it represented was 
calculated with respect to the total sample. The product 
was in compliance with the test if the percentage of 
foreign organs was not greater than 3 % and that of 
foreign elements was not greater than 1 % of the total 
sample. 
 
Identification 
The identification was carried out following 
the procedure of the senna leaf monograph of the USP 
40 [13]. To carry out the assay, a KOH solution (100 
mg of KOH/ml of 95 % alcohol) and 500 mg of product 
sample were used. First, 10 ml of KOH solution was 
added to the sample. Then, it was heated to boiling for 2 
minutes, diluted with 10 ml of water and filtered. 
Thereafter, the filtrate was acidified with concentrated 
HCl. Finally, it was stirred with ethyl ether, then the 
ethereal layer was removed and stirred with 5 ml of 6 N 
ammonium hydroxide. The assay was considered 
positive if an orange or bluish-red color was observed 
in the aqueous layer. 
 
Loss on drying assay 
The loss on drying assay was done according 
to the general chapter <731> of the USP 40 [13]. 
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Approximately 1 g of senna leaf powdered was weighed 
from each of the examined batches on an Adam® 
PW254 analytical balance using a melting pot, which 
was carried to constant weight previously. For this, the 
melting pot with the sample was placed in a Thermo 
Scientific® Heraterm oven and dried for two hours at 
105 °C. Then, it was cooled for a few minutes in a 
desiccator and the melting pot was weighed with the 
sample to calculate the loss percentage. This drying 
procedure was repeated in periods of 30 minutes until 
reaching a constant weight. According to the acceptance 
criteria established by the pharmacopoeia, the sample 
should not lose more than 12,0 % of its weight. 
 
Total ash assay 
The assay was made according to the 
procedure described in the general chapter <561> of the 
USP 40 [13]. Two tisanes were weighed accurately 
from each of the batches studied (between 2 to 4 g) on 
an Adam® PW254 analytical balance using a melting 
pot previously brought to constant weight, and 
incinerated in a Thermo Scientific® Thermolyne stove 
gently at first, gradually increasing the temperature to 
675 °C for two hours. Subsequently, the sample was 
dried at 105 °C in the Thermo Scientific® Heraterm 
oven in periods of 30 minutes until reaching a constant 
weight. The total ashes should not have been greater 
than 12,0 % for the test to be in compliance. 
 
Acid-insoluble ash assay 
The assay was carried out according to the 
procedure described in the general chapter <561> of 
USP 40 [13]. The ash obtained in the total ash test was 
heated to boil with 25 ml of HCl 3 N HCl for 5 minutes. 
Next, the remaining ash was filtered using a Boeco® 
grade 389 filter paper, washed with hot water until the 
washings did not present an acid pH and the paper was 
placed in the melting pot, previously used for the 
respective batch from which the filtered ash came from. 
Subsequently, it was incinerated in a Thermo 
Scientific® Thermolyne stove in a gentle way at the 
beginning, gradually increasing the temperature to 675 
°C for two hours. The sample was then dried at 105 °C 
in the Thermo Scientific® Heraterm oven for 30 
minutes to reach a constant weight. When determining 
the percentage of acid-insoluble ash, calculated with 
reference to the sample weight for the total ash assay, 
this should not be higher than 3,0 % to be in compliance 
with the acceptance criteria of the assay. 
 
Microbial enumeration assays 
The assays were done according to the 
procedure described in the general chapter <61> of USP 
40 [13]. For this, 10 g of each product analyzed batch 
were taken and suspended in 90 ml of Bacto
TM
 casein-
soybean digest broth. Next, two Petri dishes were 
prepared for each medium (Bacto
TM
 casein-soybean 
digest agar for mesophilic microorganisms and 
Liofilchem
TM
 potato dextrose agar for filamentous fungi 
and yeasts) at an appropriate dilution level, according to 
the limits established by the RTCA 11.03.56.09 [11]. 
The plates with casein-soybean digest agar were 
incubated at 33 °C for 48 hours, while those with 
Sabouraud dextrose agar at 22,5 °C for five days. After 
the incubation time, the colony forming units (cfu) 
present in each plate were counted, the arithmetic mean 
of the counts per batch was taken for each of the culture 
media used and the number of cfu was calculated per 
product gram. According to RTCA 11.03.56.09, the 
total mesophilic microorganism’s enumeration should 
not exceed 10
7
 cfu/g, and the filamentous fungi and 
yeasts enumeration should be no more than 10
5
 cfu/g. 
 
Specific microorganisms assays 
The procedures of the general chapter <62> of 
the USP 40 were made [13]. Initially, 10 g were 
transferred to a suitable container with 90 ml of 
Bacto
TM
 casein-soybean digest broth for its subsequent 
suspension. Then, the sample was incubated at a 
temperature of 33 °C for 24 hours. 
 
In the case of the Escherichia coli absence 
assay, a 1,0 ml aliquot of the sample was pipetted into a 
container with 100 ml Difco
TM
 MacConkey broth, 
mixed and incubated at a temperature of 44 °C for 24 
hours. After this period, a 1,0 ml sample was taken to 
inoculate two BBL
TM
 MacConkey agar Petri dishes. 
These were incubated at a temperature of 33 °C for 24 
hours. Finally, the inoculated dishes were examined. 
 
For the absence of Salmonella spp assay, an 
aliquot of 1,0 ml of the sample was taken and added to 
10,0 ml of Difco
TM
 Rappaport Vassiliadis Salmonella 
enrichment broth. It was mixed and incubated at a 
temperature of 33 °C for 24 hours. At the end of this 
period, a sample of 1,0 ml was taken to inoculate two 
plates of Difco
TM
 xylose lysine deoxycholate agar. 
These were incubated at a temperature of 33 °C for 24 
hours. 
 
Both tests were in agreement if, when 
examining the plates, there was an absence of both 
pathogenic microorganisms. 
 
RESULTS AND DISCUSSION 
The levels of the different components of the 
raw materials that make up natural products can vary 
from one batch to another, due to different 
environmental factors such as soil, altitude, temperature 
variation, atmospheric humidity, sunlight time, rain 
pattern, shadow and dew [16]. These factors have 
consequences on variations that are difficult to predict, 
to the extent that plants of the same species that are 
cultivated in distinct environments can vary 
significantly in the content of particular secondary 
metabolites [17]. Therefore, it is essential to determine 
the quality of the raw material of various batches of the 
same product, in this case, senna leaf. 
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For the tisanes batches of the senna leaf 
brands, the four items of the primary packaging and the 
19 items of the secondary packaging required for the 
products were reviewed. The summary of this review is 
shown in Table 1. Regarding the primary packaging of 
both brands, they did not provide information about the 
expiration date and the batch number. This information 
is important for tisanes, since many consumers tend to 
take them out of the secondary packaging, which is not 
optimal. In the case of the batch number, it must appear 
in order to give traceability to the product [18] in case it 
is necessary to remove the product as a consequence of 
security problems related to the product, which 
potentially avoids more dangerous situations related 
with the product [19]. 
 
Regarding the secondary packaging, 
information about the quali-quantitative composition of 
the active ingredients, the interactions, the adverse 
effects and the special legends was not observed. 
 
Table-1: Fulfillment of the primary and secondary packaging items of the different evaluated batches of two 
brands of senna leaf tisanes commercialized in Costa Rica 
Item Fulfillment 
Brand 1 Brand 2 
Batch 
1 
Batch 
2 
Batch 
3 
Batch 
4 
Batch 
5 
Batch 
6 
Primary packaging 
Brand name  Yes Yes Yes Yes Yes Yes 
Batch number No No No No No No 
Expiration date No No No No No No 
Manufacturer laboratory name or logo Yes Yes Yes Yes Yes Yes 
Secondary packaging 
Product name Yes Yes Yes Yes Yes Yes 
Pharmaceutical form Yes Yes Yes Yes Yes Yes 
Indications Yes Yes Yes Yes Yes Yes 
Employment form Yes Yes Yes Yes Yes Yes 
Quali-quantitative composition of active ingredients No No No No No No 
Registration number Yes Yes Yes Yes Yes Yes 
Manufacturer name and country of origin Yes Yes Yes Yes Yes Yes 
Net amount of the finished product  Yes Yes Yes Yes Yes Yes 
Batch number Yes Yes Yes Yes Yes Yes 
Storage conditions Yes Yes Yes Yes Yes Yes 
Expiration date Yes Yes Yes Yes Yes Yes 
Contraindications and warnings Yes Yes Yes Yes Yes Yes 
Interactions No No No No No No 
Adverse effects No No No No No No 
General labeling Yes Yes Yes Yes Yes Yes 
Special labeling No No No No No No 
Posology Yes Yes Yes Yes Yes Yes 
Administration route Yes Yes Yes Yes Yes Yes 
Use during pregnancy, breastfeeding, erlderly and 
children under 2 years 
Yes Yes Yes Yes Yes Yes 
 
In first place, there was no information on the 
quali-quantitative composition of the active ingredients 
of the analyzed products. This information must be 
provided to consumers, since they must be clear that the 
properties as a laxative are due to senosides A and B, 
that the quantities in which they are found, which 
allows to ensure that the pharmacological properties of 
the product are assured despite the harvest, packaging 
and storage processes to which the raw material is 
subjected [20]. 
 
Another aspect that is not present in the 
labeling are the interactions. It is known that the abuse 
of the laxative effect for a prolonged period can 
produce hypokalemia and potentiate the action of 
cardiac glycosides and interact with antiarrhythmic 
products that induce the reversion of the sinus rhythm 
(quinidine) and with products that produce the 
prolongation of the QT wave. As wise, the concomitant 
use with other products that induce hypokalemia 
(diuretics and adrenocorticoids) can increase the 
electrolyte imbalance [21]. In addition, it can increase 
the effect of digoxin [22, 23]. Likewise, information 
related to adverse effects should be considered, since 
cases have been reported as a consequence of the use of 
senna leaf, among them, hepatotoxicity, hepatitic, portal 
venous thrombosis and paralytic ileus [24, 25]. 
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Also, special labeling regarding their use 
should be present. It is known that there are different 
conditions in which the consumption of senna leaf is 
not recommended. Some of them are electrolyte 
disturbances, potassium deficiency, dehydration, 
diarrhea, gastrointestinal conditions (intestinal 
blockage, Crohn's disease, ulcerative colitis, 
appendicitis, stomach inflammation, prolapse, 
hemorrhoids) and heart disease [26]. 
 
Regarding the results obtained for the 
minimum fill assay (Table 2), for brand 1, the tisane 
content was 1,1 g, while for brand 2 the indicated 
weight was 1,3 g. The labeling average percentage of 
each of the analyzed batches showed a value above 
what was declared on the labeling and no tisane showed 
content lower than 90 % of that labeling. This allows to 
have a notion of whether the dose administered by each 
tisane meets the specification (average of 10 tisanes not 
less than 100 % of the product labeling and no tisane 
with a minimum fill less than 90 % of that indicated in 
the product). For the three batches of the two brands it 
was found that there was a consistent result regarding 
these criteria. However, in three of the studied batches 
(two of brand 1 and one of brand 2) labeling average 
percentage over 110 % were found, with one of brand 2 
reaching a value of 120 %. This represents a warning 
for the manufacturer companies, since high values can 
cause that the administered dose go from therapeutic to 
toxic, depending on the appropriate dose (20 to 60 mg 
of sennosides per day in the case of adults and half of 
the adult dose for children over six years old [27]), 
which can not be determined with the information 
present on the labeling of these products, as the quali-
quantitative composition is not taken into account. 
 
Table-2: Labeling percentage of the different evaluated batches of two brands of senna leaf tisanes 
commercialized in Costa Rica. 
Tisane Labeling percentage (%) 
Brand 1 Brand 2 
Batch 1 Batch 2 Batch  3 Batch 4 Batch 5 Batch 6 
1 108 120 105 104 109 122 
2 108 121 116 114 109 122 
3 107 114 115 107 105 117 
4 105 114 108 102 109 117 
5 103 113 111 109 110 127 
6 103 115 112 112 105 121 
7 104 117 117 115 103 118 
8 106 115 111 110 110 117 
9 106 119 115 116 97 117 
10 105 115 115 113 102 119 
Average 105 116 113 110 106 120 
 
Therefore, a stricter control over the filling is 
required to obtain a greater safety in terms of reaching 
the dose range at which the active principle is effective 
without generating unacceptable adverse effects [28]. 
 
Another assay was the organoleptic 
characteristics, (done through a careful visual 
observation) to have a notion that the content of the 
tisane consists of senna leaf and not another vegetable 
species. The organoleptic characteristics are important, 
given that these attributes make it possible to 
distinguish between medicinal and non-medicinal plants 
[29]. In this case, all the evaluated batches for the two 
senna leaf brands were in compliance with the color, 
odor and texture characteristics. 
 
To complement the previous test, the presence 
of foreign organs (senna parts different from the leave) 
and foreign elements (material distinct from the senna 
plant) was determined. In many cases, the adulteration 
of plant material occurs through substitution with 
inferior commercial varieties, artificially produced 
substances, cheaper plants or vegetative parts other than 
those that have the desired therapeutic effect [30]. In the 
case of senna, the vegetative part used is the leaf [31]. 
For the analyzed products, Table 3 shows that all the 
batches showed a percentage of foreign organs of 1%, 
with which they were found according to what was 
established by the BP [14]. Within this same test, the 
presence of foreign materials was not found in the 
analyzed samples of the batches of both products, 
which shows the quality of the raw material used to 
make the teas. 
 
Another essential test to ensure that the 
material exerts its desired therapeutic effect is that of 
identification. Said confirmation was due to the fact that 
in all cases the formation of a similar orange coloration 
occurred for the three batches shown of each senna leaf 
product. Also, it was possible to confirm the presence 
of sennosides in the batches of tisanes analyzed. Also, it 
was found that the presence of sennosides was similar 
for the three batches of each of the brands. This result 
shows that the raw material has not undergone 
variations in its composition, due to the environmental 
conditions to which it was subjected. However, it also 
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reaffirms that the control of the minimum fill of the 
herbal teas must be stricter, because for the same batch, 
a person may be consuming a certain amount of 
sennosides A and B one day, and the next day, a larger 
amount. With this, the intended effect will not be 
maintained over time, but may experience greater or 
lesser effects depending on the tisane or tisanes that 
have been used on a certain day to consume the senna 
leaf product. 
 
With respect to the loss on drying assay (Table 
4), all the values were below 12,0 %, for which the 
different batches studied were in compliance with that 
established by the USP 40 [13]. Reducing humidity is 
necessary to prevent the active agents of the plant 
material from being destroyed and their properties to 
become unfavorable [32].Therefore, the objective of 
drying natural products is to extend their useful life and 
preserve their characteristics. In addition, by reducing 
the water activity of the products, it is intended to 
inhibit the growth and development of pathogenic 
microorganisms or that may be capable of deteriorating 
the product [33]. In the case of analyzed products, their 
water content is ideal to ensure the expiration date 
established for the different batches, and the 
maintenance of the required characteristics for an 
adequate pharmacological response by the active 
components that produce the laxative effect in the senna 
leaf. 
 
Table-3: Percentage of foreign organs and foreign elements of the different evaluated batches of two brands of 
senna leaf tisanes commercialized in Costa Rica 
Brand 1 
Sample Batch 1 Batch 2 Batch 3 
Weight 
(g) 
Percentage within 
the total (%) 
Weight 
(g) 
Percentage within 
the total (%) 
Weight 
(g) 
Percentage within 
the total (%) 
Initial 11,5478 100 12,4434 100 12,1357 100 
Foreing 
organs 
0,0669 1 0,1036 1 0,0898 1 
Foreign 
elements 
0 0 0 0 0 0 
Brand 2 
Sample Batch 4 Batch 5 Batch 6 
Weight 
(g) 
Percentage within 
the total (%) 
Weight 
(g) 
Percentage within 
the total (%) 
Weight 
(g) 
Percentage within 
the total (%) 
Initial 14,1955 100 13,4355 100 15,1384 100 
Foreign 
organs 
0,1139 1 0,0605 0 0,0788 1 
Foreign 
elements 
0 0 0 0 0 0 
 
Table-4: Loss on drying percentage of the different evaluated batches of two brands of senna leaf tisanes 
commercialized in Costa Rica 
Brand Batch Initial weight (g) Final weight (g) Loss on drying percentage (%) 
 
1 
1 1,2148 1,0970 9,7 
2 1,2719 1,1488 9,7 
3 1,2287 1,1076 9,9 
 
2 
4 1,5547 1,4011 9,9 
5 1,5195 1,3696 9,9 
6 1,4753 1,3300 9,8 
 
Likewise, in Table 5 it is observed that for the 
total ash and acid-insoluble ash assays there was a 
compliance with respect to that specified by this same 
pharmacopoeia for the products constituted by senna 
leaf. The total ash assay is developed to measure the 
amount of inorganic material that remains after the 
ignition of the vegetal material [34], and includes the 
plant's own ash, as well as that coming from the sand 
and the soil adhered to the product [35]. Its 
determination indicates the care with which the 
preparation of the vegetable raw material was carried 
out [36]. In what corresponds to the batches analyzed, it 
is possible to mention that the raw materials used have 
been prepared in a careful way to avoid the presence of 
material other than the required plant material. This is 
shown in this table, where the percentage of total ash 
for the batches of brand 1 was between 7,8 and 8,1 %, 
while for those of the brand 2 was between 7,7 and 8,4 
%. These values are well below the 12 % specified by 
USP [13], demonstrating the quality in the preparation 
of the material. 
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Table-5: Total ash and insoluble-acid ash percentage of the different evaluated batches of two brands of senna leaf 
tisanes commercialized in Costa Rica 
Brand Batch Initial 
weight (g) 
Total ash 
weight (g) 
Total ash 
percentage (%) 
Insoluble-acid ash 
weight (g) 
Insoluble-acid ash 
percentage (%) 
 
1 
1 2,3029 0,1854 8,1 0,0119 0,5 
2 2,4771 0,1925 7,8 0,0059 0,2 
3 2,5651 0,1998 7,8 0,0104 0,4 
 
2 
4 3,0781 0,2455 8,0 0,0102 0,3 
5 2,9014 0,2238 7,7 0,0167 0,6 
6 3,0911 0,2610 8,4 0,0248 0,8 
 
However, because the total ash test is not 
always reliable, because there is a possibility of the 
presence of non-physiological substances such as earthy 
materials [36], including silica [37]. So, it is necessary 
to carry out the acid-insoluble ash assay. In the case of 
the samples analyzed, the percentages obtained were 
less than 1 %. This is another indication of the quality 
of the raw material used in the preparation of senna leaf 
tisanes for both brands. 
 
Finally, a series of assays were carried out to 
know the microbiological quality of the different brands 
for both products. The concern about this quality in the 
products is due to the potential contamination, 
considering their natural origin [38]. It is known that 
natural products usually contain bacteria and yeasts 
from the soil and the atmosphere. Moreover, soil, 
harvest, drying, storage conditions and inadequate 
handling influence on microbiological quality. This 
represents a serious problem, since the presence of 
microbiological contaminants can reduce or even 
inactivate the therapeutic activity of the products and 
has the potential to adversely affect the patients who 
consume them [39, 40]. As regards, the results obtained 
for the three batches of each one of the products studied 
were consistent for mesophilic aerobic microorganism 
enumeration, as well as for filamentous fungi and yeasts 
enumeration, as seen in Table 6. This shows that the 
companies of these products in Costa Rica have been 
concerned with ensuring adequate handling of the plant 
material at all stages of the production of senna leaf 
tisanes. 
 
Table-6: Compliance of the different batches evaluated of two brands of senna leaf tisanes commercialized in 
Costa Rica with respect to the distinct microbiological tests carried out. 
Assay Compliance 
Brand 1 Brand 2 
Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 Batch 6 
Mesophilic aerobic microorganism enumeration Yes Yes Yes Yes Yes Yes 
Filamentous fungi and yeasts enumeration Yes Yes Yes Yes Yes Yes 
E. coli absence Yes Yes Yes Yes Yes Yes 
Salmonella sp. absence Yes Yes Yes Yes Yes Yes 
 
To complete this microbiological control, the 
presence or absence of E. coli and Salmonella sp. was 
determined in these products. Salmonella sp. should be 
evaluated, because when ingested orally it is capable of 
generating gastroenteritis, which manifests as nausea, 
vomiting and diarrhea between 6 and 48 hours after 
ingestion [41], while E. coli is also capable of causing 
enteritis, enterocolitis and colitis when the person 
ingests it in sufficient quantity [42]. The regulation of 
Costa Rica only requires the development of tests for 
the absence of E. coli for products that are consumed 
using boiling water, but not for Salmonella sp, since 
this microorganism does not resist water at its boiling 
point [43]. However, because in this country many 
people consume tea using hot water, Salmonella sp is 
able to withstand these temperatures and become a 
potential hazard if it is presented. For the batches of the 
brands of interest, all agreed for the absence tests of 
these two pathogens, with which there is no danger for 
the consumer of being exposed to bacteria capable of 
developing serious problems in the gastrointestinal 
system. 
 
In future research, we hope to continue 
obtaining information on the quality of other raw 
materials commercialized in as tisanes in Costa Rica, 
which have their respective monographs in 
pharmacopoeias accepted as officials in this country.  
 
CONCLUSIONS 
The senna leaf is a natural raw material widely 
used for its laxative effects. In the case of the three 
batches of each brand commercialized in Costa Rica, 
they were in compliance in regard with minimum fill, 
organoleptic, foreign organic matter, identification, loss 
on drying, total ash, acid-insoluble ash, microbial 
enumerations and specific microorganisms assays. 
However, both brands do not comply with six of the 23 
items required for primary and secondary packaging 
(batch number, expiration date, quali-quantitative 
composition of active ingredients, interactions, adverse 
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effects and special labeling). For all of the above, the 
raw material commercialized in Costa Rica meet the 
quality standards according with the requirements of the 
RTCA. The companies in charge of its production must 
pay attention in the inclusion of the items missing in the 
labeling and in the improvement of the filling process 
controls of the herbal tea, so that its quantity will be 
closer to that established in the labeling. In this way, a 
product that provides greater safety for consumers of 
this herbal product will be obtained. Likewise, it is 
possible to mention that there is reproducibility for the 
characteristics of the senna leaf between the different 
batches in each one of the two commercialized brands. 
This is an indication that the raw material used 
maintains the quality characteristics required to favor its 
efficiency and safety. 
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